A Real-world Study of Liposomal Irinotecan (Onivyde)-Based Therapy in Patients With Locally Advanced/Metastatic Pancreatic Cancer in China
Clinical trial NCT07026123 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07026123
- Sponsor
- RenJi Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-07-01
- Primary completion
- 2027-07-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.